HealthPhoto: DNA IndiaNo Price Reduction in Key Cancer Drug MRPs as per NPPA List
The NPPA's revised maximum retail price list for non-scheduled anti-cancer drugs, effective November 9, 2026, shows no change in prices of major cancer drugs like Keytruda (Rs 2.16 lakh) and Alecensa (Rs 4.3 lakh). Prices of patented medicines for lung, breast, blood cancer, and bone marrow conditions remain unchanged, offering no immediate relief to patients despite trade margin regulations.
DNA India·


